Amgen v. Sandoz - New Developments in Biosimilars Litigation

Published date24 May 2019
Subject MatterFDA,Patents,Biosimilars,Noninfringement,Pharmaceutical Patents,Patent Infringement,Sandoz v Amgen,aBLA
AuthorMargaux Nair,Devon Beane
Law FirmK&L Gates LLP

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT